Bioqual Share Holder Equity 2010-2024 | BIOQ
Bioqual share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Bioqual Annual Share Holder Equity
(Millions of US $) |
| 2024 |
$38 |
| 2023 |
$38 |
| 2022 |
$38 |
| 2021 |
$34 |
| 2020 |
$28 |
| 2019 |
$25 |
| 2018 |
$22 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$0 |
Bioqual Quarterly Share Holder Equity
(Millions of US $) |
| 2024-08-31 |
$37 |
| 2024-05-31 |
$38 |
| 2024-02-29 |
$39 |
| 2023-11-30 |
$39 |
| 2023-08-31 |
$39 |
| 2023-05-31 |
$38 |
| 2023-02-28 |
$38 |
| 2022-11-30 |
$39 |
| 2022-08-31 |
$39 |
| 2022-05-31 |
$38 |
| 2022-02-28 |
$36 |
| 2021-11-30 |
$35 |
| 2021-08-31 |
$35 |
| 2021-05-31 |
$34 |
| 2021-02-28 |
$31 |
| 2020-11-30 |
$30 |
| 2020-08-31 |
$30 |
| 2020-05-31 |
$28 |
| 2020-02-29 |
$27 |
| 2019-11-30 |
$26 |
| 2019-08-31 |
$0 |
| 2019-05-31 |
$25 |
| 2019-02-28 |
$0 |
| 2018-11-30 |
$0 |
| 2018-08-31 |
|
| 2018-05-31 |
$22 |
| 2018-02-28 |
|
| 2017-11-30 |
|
| 2017-08-31 |
|
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
|
| 2015-11-30 |
|
| 2015-08-31 |
|
| 2015-05-31 |
|
| 2015-02-28 |
|
| 2014-08-31 |
|
| 2014-05-31 |
|
| 2013-11-30 |
|
| 2013-08-31 |
|
| 2013-05-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
|
| 2011-02-28 |
|
| 2010-11-30 |
|
| 2010-08-31 |
|
| 2010-05-31 |
|
| 2010-02-28 |
|
| 2009-11-30 |
|
| 2009-08-31 |
$0 |
| 2009-05-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.059B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
